2001
DOI: 10.1002/lsm.1050
|View full text |Cite
|
Sign up to set email alerts
|

Long‐term results in the treatment of childhood hemangioma with the flashlamp‐pumped pulsed dye laser: An evaluation of 617 cases

Abstract: In the vast majority of the hemangiomas, it was possible to stop further progression or induce regression by FPDL treatment. Total regression could be achieved in nearly half of the small superficial hemangiomas. Because the treatment is fast, effective, and nearly without side effects, we recommend early laser treatment especially in superficial and small childhood hemangiomas.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

3
70
1
7

Year Published

2003
2003
2012
2012

Publication Types

Select...
4
2

Relationship

0
6

Authors

Journals

citations
Cited by 94 publications
(81 citation statements)
references
References 16 publications
3
70
1
7
Order By: Relevance
“…Due to its limited depth of penetration, it does not reach the deeper dermal vasculature of the skin, and it is therefore not surprising that the deeper component of hemangiomas can continue to proliferate despite laser therapy [19]. In superficial hemangiomas, however, a number of published studies report significant lightening and thinning following treatment with the PDL during the proliferative phase [12][13][14][15][16][17][18] (Table 2). Most reports note a low risk of scarring or other adverse outcome, ranging from none to a rate of 4% [1,[13][14][15][16][17][18].…”
Section: Discussionmentioning
confidence: 99%
See 4 more Smart Citations
“…Due to its limited depth of penetration, it does not reach the deeper dermal vasculature of the skin, and it is therefore not surprising that the deeper component of hemangiomas can continue to proliferate despite laser therapy [19]. In superficial hemangiomas, however, a number of published studies report significant lightening and thinning following treatment with the PDL during the proliferative phase [12][13][14][15][16][17][18] (Table 2). Most reports note a low risk of scarring or other adverse outcome, ranging from none to a rate of 4% [1,[13][14][15][16][17][18].…”
Section: Discussionmentioning
confidence: 99%
“…In superficial hemangiomas, however, a number of published studies report significant lightening and thinning following treatment with the PDL during the proliferative phase [12][13][14][15][16][17][18] (Table 2). Most reports note a low risk of scarring or other adverse outcome, ranging from none to a rate of 4% [1,[13][14][15][16][17][18]. Some authors advocate early treatment of uncomplicated superficial hemangiomas in the preproliferative or early proliferative phases to prevent further proliferation and associated complications [17,18].…”
Section: Discussionmentioning
confidence: 99%
See 3 more Smart Citations